The recombination signal binding protein for immunoglobulin kappa J region (RBPJ) has a dual effect on Kaposi’s sarcoma-associated herpesvirus (KSHV) replication. RBPJ interaction with replication and transcription activator (RTA) is essential for lytic replication, while the interaction with latency-associated nuclear antigen (LANA) facilitates latent infection. Furthermore, our previous study found that LANA decreased RBPJ through upregulating miRNA let-7a. However, it is unclear whether RTA regulates the expression of RBPJ. Here, we show RTA increases RBPJ by decreasing let-7a. During KSHV replication, the RBPJ expression level was positively correlated with the RTA expression level and negatively correlated with the LANA expression level. The let-7a expression level was inverse to RBPJ. Knockdown of RBPJ inhibited the self-activation of RTA promoter and LANA promoter and weakened LANA’s inhibition of RTA promoter. Collectively, these findings indicate that RTA and LANA compete for let-7a/RBPJ signal to control the KSHV replication. Regulating the RBPJ expression level by RTA and LANA plays an important role during KSHV replication.

BackgroundHypertension is rising as a major public health burden around the world. This study explored the association between single-nucleotide polymorphisms (SNPs) in the adenosine triphosphate (ATP)-Binding Cassette Subfamily A1 (ABCA1) gene and hypertension among Chinese Han adults.MethodA total of 2,296 Han Chinese in southeast China were recruited for this study. We collected medical reports, lifestyle details, and blood samples from individuals. The polymerase chain reaction-ligase detection reaction (PCR-LDR) method was used to detect the genotypes of these SNPs in the ABCA1 gene.ResultsAfter adjusting some covariates, the additive and recessive models of the rs2472510 and rs2515614 were significantly associated with hypertension. The haplotypes TCTA (rs2297406-rs2472433-rs2472510-rs2515614) were associated with high SBP, and the haplotypes CCTA, TCTA, and TTTA were associated with high diastolic blood pressure (DBP).ConclusionThe results of the relationship between the polymorphisms of rs2297406, rs2472433, rs2472510, and rs2515614 in ABCA1 and hypertension in southeastern China would provide a theoretical basis for genetic screening and disease prevention.

BackgroundPreoperative carbohydrate loading is an important element of the enhanced recovery after surgery (ERAS) paradigm in adult patients undergoing elective surgery. However, preoperative carbohydrate loading remains controversial in terms of improvement in postoperative outcomes and safety. We conducted a Bayesian network meta-analysis to evaluate the effects and safety of different doses of preoperative carbohydrates administrated in adult patients after elective surgery.MethodsMEDLINE (PubMed), Web of Science, EMBASE, EBSCO, the Cochrane Central Register of Controlled Trials, and China National Knowledge Infrastructure (CNKI) were searched to identify eligible trials until 16 September 2022. Outcomes included postoperative insulin resistance, residual gastric volume (RGV) during the surgery, insulin sensitivity, fasting plasma glucose (FPG), fasting serum insulin (Fin) level, the serum levels of C-reactive protein (CRP), postoperative scores of pain, patients’ satisfaction, thirst, hunger, anxiety, nausea and vomit, fatigue, and weakness within the first 24 h after surgery and the occurrences of postoperative infection. The effect sizes were estimated using posterior mean difference (continuous variables) or odds ratios (dichotomous variables) and 95 credible intervals (CrIs) with the change from baseline in a Bayesian network meta-analysis with random effect.ResultsFifty-eight articles (N = 4936 patients) fulfilled the eligibility criteria and were included in the meta-analysis. Both preoperative oral low-dose carbohydrate loading (MD: –3.25, 95% CrI: –5.27 to –1.24) and oral high-dose carbohydrate loading (MD: –2.57, 95% CrI: –4.33 to –0.78) were associated with postoperative insulin resistance compared to placebo/water. When trials at high risk of bias were excluded, association with insulin resistance was found for oral low-dose carbohydrate loading compared with placebo/water (MD: –1.29, 95%CrI: –2.26 to –0.27) and overnight fasting (MD: –1.17, 95%CrI: –1.88 to –0.43). So, there was large uncertainty for all estimates vs. control groups. In terms of safety, oral low-dose carbohydrate administration was associated with the occurrences of postoperative infection compared with fasting by 0.42 (95%Crl: 0.20–0.81). In the other outcomes, there was no significant difference between the carbohydrate and control groups.ConclusionAlthough preoperative carbohydrate loading was associated with postoperative insulin resistance and the occurrences of postoperative infection, there is no evidence that preoperative carbohydrate administration alleviates patients’ discomfort.Systematic review registration[https://www.crd.york.ac.uk/PROSPERO/], identifier [CRD42022312944].

Deoxynivalenol (DON) together with its acetylated derivatives cause detrimental effects on human health, and the purpose of this study was to assess the prevalence of DON and its acetylated derivatives from grains and grain products in Zhejiang province, China, and to assess the risk of DON and its acetylated derivatives due to multiple consumptions of grains and grain products among the Zhejiang population. Food samples numbering 713 were collected, and the LC-MS/MS method was used to determine the toxins. The levels of toxins from grains and grain products were relatively low: DON was the toxin at the highest levels. The food frequency questionnaire was used to collect food consumption data. The result of exposure assessments showed that the population was overall at low levels of toxin exposure. The probable mean group daily intake of toxins was 0.21 μg/kg bw/day, which was far from the group provisional maximum tolerable daily intake of 1 μg/kg bw/day, but 0.71% of participants were at high exposure levels. Rice and dried noodles (wheat-based food) were the main sources of toxin exposure, and reducing the consumption of rice and dried noodles while consuming more of other foods with lower levels of toxins is recommended.

Background The World Health Organization (WHO) recommends bedaquiline (BDQ) as a Group A drug for the treatment of multi-drug resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB). This systematic review and meta-analysis aimed to evaluate the efficacy and safety of BDQ-containing regimens for the treatment of pulmonary TB patients. Methods MEDLINE (PubMed), EBSCO, the Cochrane Central Register of Controlled Trials and CNKI (China National Knowledge Infrastructure) were searched to identify eligible trials until September 8, 2022, for randomized controlled trials (RCTs) and non-randomized studies (NRSs) where BDQ was administered to patients with TB. Outcomes of interest were: (1) efficacy, including the rate of sputum culture conversion at 8 weeks, 24 weeks, and follow-up, and the rate of complete, cure, death, failure, and lost to follow-up at end of the treatment. (2) safety, which includes the incidence of cardiotoxicity, hepatotoxicity, and grade 3–5 adverse events during the treatment. Results A total of 29 articles (N = 23,358) fulfilled the eligibility criteria and were included in the meta-analysis. Compared with the BDQ-unexposed patients, The BDQ-containing regimen improved the rate of sputum conversion in RCTs (24 weeks: RR = 1.27, 95%Cl:1.10 to 1.46, follow-up: RR = 1.33, 95%Cl:1.06 to 1.66) and increased cure rate (RR = 1.60, 95%Cl: 1.13 to 2.26), and it also decreased the failure rate by 0.56 (95%Cl: 0.56 to 0.88). In NRSs, BDQ-containing regimen improved the sputum culture conversion rate (follow-up: RR = 1.53, 95%Cl: 1.07 to 2.20) and the rate of cure (RR = 1.86,95%Cl:1.23 to 2.83), reduced the rate of all-cause death (RR = 0.68, M-H random-effects 95%Cl: 0.48 to 0.97) and failure (RR = 0.57, 95%Cl:0.46 to 0.71). In terms of safety, BDQ-containing regimen administration increased the incidence of cardiotoxicity (RR = 4.54, M-H random-effects 95%Cl: 1.74–11.87) and grade 3–5 adverse events (RR = 1.42, M-H random-effects 95%Cl: 1.17–1.73) in RCTs; NRSs showed cardiotoxicity was associated with BDQ-containing regimen (RR = 6.00, M-H random-effects 95%Cl: 1.32–27.19). In the other outcomes, there was no significant difference between the intervention and control groups. Conclusions RCTs and NRSs data support the efficacy of BDQ for pulmonary TB, but cardiotoxicity and serious adverse events of BDQ were frequent. Overall, there is a lack of comparative data on efficacy and safety. Due to the serious risk of bias and discrepancy, further confirmation is needed.